{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,26]],"date-time":"2025-12-26T11:30:50Z","timestamp":1766748650154,"version":"build-2065373602"},"reference-count":67,"publisher":"MDPI AG","issue":"21","license":[{"start":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T00:00:00Z","timestamp":1761696000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Guangdong Medical Science and Technology Research Fund Project","award":["A2024716"],"award-info":[{"award-number":["A2024716"]}]},{"name":"Maoming Municipal Science and Technology Bureau Special Plan","award":["2023SZX029"],"award-info":[{"award-number":["2023SZX029"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Background: We aimed to identify key molecular drivers of gastric cancer progression and poor prognosis by integrating multi-omics analyses with experimental validation. Methods: Single-cell RNA-seq data were clustered to delineate major cell types. InferCNV identified tumor epithelial cells, and reclustering revealed a malignant subset with poor prognosis. The overlap between subset markers and The Cancer Genome Atlas Stomach Adenocarcinoma (TCGA-STAD) upregulated differentially expressed genes (DEGs) was modeled with univariate, LASSO-, and multivariate Cox to derive a prognostic signature. Patients were stratified according to signature scores, and group differences in survival and immunologic features were compared. Spatial transcriptomics defined the localization patterns of key signature genes. In vitro functional assays (CCK-8, colony formation, EdU incorporation, flow cytometry, Transwell migration and invasion, and wound healing) confirmed the pivotal role of SRI. Results: Reclustering of tumor epithelial cells yielded seven subsets (C0\u2013C6), with C5 displaying marked malignant features and correlating with poor prognosis in multiple cohorts. Intersecting 208 genes yielded a five-gene signature (ASCL2, REPIN1, CXCL3, TMEM176A, SRI). The signature stratified patients into high- and low-risk groups. The high-risk cohort exhibited significantly poorer survival, distinct immune-infiltration patterns, elevated immune-evasion scores, and a reduced predicted response to immunotherapy. Single-cell and spatial transcriptomics localized TMEM176A to fibroblasts and SRI to the tumor epithelium. Finally, in vitro knockdown of SRI inhibited tumor cell proliferation, migration and invasion. Conclusions: Our multi-omics approach identified a malignant epithelial subset, C5, and a five-gene signature that stratifies gastric cancer prognosis and immune response. Functional assays showed that SRI knockdown impairs tumor cell growth, migration and invasion.<\/jats:p>","DOI":"10.3390\/cancers17213483","type":"journal-article","created":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T00:50:19Z","timestamp":1761785419000},"page":"3483","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Integrated Multi-Omics Analysis Identifies SRI as a Critical Target Promoting Gastric Cancer Progression and Associated with Poor Prognosis"],"prefix":"10.3390","volume":"17","author":[{"given":"Zhijie","family":"Gong","sequence":"first","affiliation":[{"name":"The First School of Clinical Medicine, Southern Medical University, Guangzhou 510515, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiwei","family":"Wang","sequence":"additional","affiliation":[{"name":"Second Department of Gastrointestinal Surgery, Maoming People\u2019s Hospital, Maoming Clinical Medical College, Guangdong Medical University, Maoming 525000, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yinghao","family":"He","sequence":"additional","affiliation":[{"name":"The First School of Clinical Medicine, Southern Medical University, Guangzhou 510515, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Zhou","sequence":"additional","affiliation":[{"name":"Second Department of Gastrointestinal Surgery, Maoming People\u2019s Hospital, Maoming Clinical Medical College, Guangdong Medical University, Maoming 525000, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiangbang","family":"Yang","sequence":"additional","affiliation":[{"name":"Second Department of Gastrointestinal Surgery, Maoming People\u2019s Hospital, Maoming Clinical Medical College, Guangdong Medical University, Maoming 525000, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aiwen","family":"Feng","sequence":"additional","affiliation":[{"name":"Second Department of Gastrointestinal Surgery, Maoming People\u2019s Hospital, Maoming Clinical Medical College, Guangdong Medical University, Maoming 525000, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zudong","family":"Huang","sequence":"additional","affiliation":[{"name":"Second Department of Gastrointestinal Surgery, Maoming People\u2019s Hospital, Maoming Clinical Medical College, Guangdong Medical University, Maoming 525000, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian","family":"Pan","sequence":"additional","affiliation":[{"name":"Second Department of Gastrointestinal Surgery, Maoming People\u2019s Hospital, Maoming Clinical Medical College, Guangdong Medical University, Maoming 525000, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingze","family":"Li","sequence":"additional","affiliation":[{"name":"Second Department of Gastrointestinal Surgery, Maoming People\u2019s Hospital, Maoming Clinical Medical College, Guangdong Medical University, Maoming 525000, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3902-5013","authenticated-orcid":false,"given":"Xiaolu","family":"Yuan","sequence":"additional","affiliation":[{"name":"Second Department of Gastrointestinal Surgery, Maoming People\u2019s Hospital, Maoming Clinical Medical College, Guangdong Medical University, Maoming 525000, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minghui","family":"Ma","sequence":"additional","affiliation":[{"name":"The First School of Clinical Medicine, Southern Medical University, Guangzhou 510515, China"},{"name":"Second Department of Gastrointestinal Surgery, Maoming People\u2019s Hospital, Maoming Clinical Medical College, Guangdong Medical University, Maoming 525000, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,10,29]]},"reference":[{"key":"ref_1","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s13045-023-01451-3","article-title":"Gastric cancer treatment: Recent progress and future perspectives","volume":"16","author":"Guan","year":"2023","journal-title":"J. Hematol. Oncol."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"K\u00f6rfer, J., Lordick, F., and Hacker, U.T. (2021). Molecular Targets for Gastric Cancer Treatment and Future Perspectives from a Clinical and Translational Point of View. Cancers, 13.","DOI":"10.3390\/cancers13205216"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/s41591-018-0014-x","article-title":"Understanding the tumor immune microenvironment (TIME) for effective therapy","volume":"24","author":"Binnewies","year":"2018","journal-title":"Nat. Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"235","DOI":"10.5230\/jgc.2019.19.e25","article-title":"Clinical Implementation of Precision Medicine in Gastric Cancer","volume":"19","author":"Jeon","year":"2019","journal-title":"J. Gastric Cancer"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"The Cancer Genome Atlas Research Network (2014). Comprehensive molecular characterization of gastric adenocarcinoma. Nature, 513, 202\u2013209.","DOI":"10.1038\/nature13480"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S0140-6736(10)61121-X","article-title":"Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): A phase 3, open-label, randomised controlled trial","volume":"376","author":"Bang","year":"2010","journal-title":"Lancet"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1001\/jamaoncol.2021.0275","article-title":"Assessment of Pembrolizumab Therapy for the Treatment of Microsatellite Instability-High Gastric or Gastroesophageal Junction Cancer Among Patients in the KEYNOTE-059, KEYNOTE-061, and KEYNOTE-062 Clinical Trials","volume":"7","author":"Chao","year":"2021","journal-title":"JAMA Oncol."},{"key":"ref_9","first-page":"5681","article-title":"Use of immunotherapy in the treatment of gastric cancer","volume":"18","author":"Yang","year":"2019","journal-title":"Oncol. Lett."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"152","DOI":"10.3892\/ol.2024.14285","article-title":"Applications of single-cell omics and spatial transcriptomics technologies in gastric cancer (Review)","volume":"27","author":"Ren","year":"2024","journal-title":"Oncol. Lett."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/s41591-020-1125-8","article-title":"Single-cell dissection of intratumoral heterogeneity and lineage diversity in metastatic gastric adenocarcinoma","volume":"27","author":"Wang","year":"2021","journal-title":"Nat. Med."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1136\/gutjnl-2019-320368","article-title":"Dissecting transcriptional heterogeneity in primary gastric adenocarcinoma by single cell RNA sequencing","volume":"70","author":"Zhang","year":"2021","journal-title":"Gut"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/s41587-022-01448-2","article-title":"The expanding vistas of spatial transcriptomics","volume":"41","author":"Tian","year":"2023","journal-title":"Nat. Biotechnol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1038\/s41588-024-01914-4","article-title":"Spatial transcriptomic analysis of primary and metastatic pancreatic cancers highlights tumor microenvironmental heterogeneity","volume":"56","author":"Khaliq","year":"2024","journal-title":"Nat. Genet."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/s41587-023-01767-y","article-title":"Dictionary learning for integrative, multimodal and scalable single-cell analysis","volume":"42","author":"Hao","year":"2024","journal-title":"Nat. Biotechnol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1038\/s41592-019-0619-0","article-title":"Fast, sensitive and accurate integration of single-cell data with Harmony","volume":"16","author":"Korsunsky","year":"2019","journal-title":"Nat. Methods"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1126\/science.1254257","article-title":"Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma","volume":"344","author":"Patel","year":"2014","journal-title":"Science"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1038\/nmeth.4402","article-title":"Reversed graph embedding resolves complex single-cell trajectories","volume":"14","author":"Qiu","year":"2017","journal-title":"Nat. Methods"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1126\/science.aax0249","article-title":"Single-cell transcriptional diversity is a hallmark of developmental potential","volume":"367","author":"Gulati","year":"2020","journal-title":"Science"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1038\/s41467-021-21246-9","article-title":"Inference and analysis of cell-cell communication using CellChat","volume":"12","author":"Jin","year":"2021","journal-title":"Nat. Commun."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1089\/omi.2011.0118","article-title":"clusterProfiler: An R package for comparing biological themes among gene clusters","volume":"16","author":"Yu","year":"2012","journal-title":"Omics"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"5381","DOI":"10.1002\/sim.5958","article-title":"Estimating and comparing time-dependent areas under receiver operating characteristic curves for censored event times with competing risks","volume":"32","author":"Blanche","year":"2013","journal-title":"Stat. Med."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"H\u00e4nzelmann, S., Castelo, R., and Guinney, J. (2013). GSVA: Gene set variation analysis for microarray and RNA-seq data. BMC Bioinform., 14.","DOI":"10.1186\/1471-2105-14-7"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Maeser, D., Gruener, R.F., and Huang, R.S. (2021). oncoPredict: An R package for predicting in vivo or cancer patient drug response and biomarkers from cell line screening data. Brief. Bioinform., 22.","DOI":"10.1093\/bib\/bbab260"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/S0140-6736(20)31288-5","article-title":"Gastric cancer","volume":"396","author":"Smyth","year":"2020","journal-title":"Lancet"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"131","DOI":"10.5009\/gnl.2014.8.2.131","article-title":"Immune response and the tumor microenvironment: How they communicate to regulate gastric cancer","volume":"8","author":"Lee","year":"2014","journal-title":"Gut Liver"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s13073-022-01075-1","article-title":"An introduction to spatial transcriptomics for biomedical research","volume":"14","author":"Williams","year":"2022","journal-title":"Genome Med."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1186\/s12967-023-04150-2","article-title":"Advances in spatial transcriptomics and related data analysis strategies","volume":"21","author":"Du","year":"2023","journal-title":"J. Transl. Med."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","article-title":"Hallmarks of Cancer: New Dimensions","volume":"12","author":"Hanahan","year":"2022","journal-title":"Cancer Discov."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1038\/nrc.2016.73","article-title":"The biology and function of fibroblasts in cancer","volume":"16","author":"Kalluri","year":"2016","journal-title":"Nat. Rev. Cancer"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"4557","DOI":"10.1158\/0008-5472.CAN-18-3962","article-title":"The Tumor Microenvironment Innately Modulates Cancer Progression","volume":"79","author":"Hinshaw","year":"2019","journal-title":"Cancer Res."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.immuni.2013.07.012","article-title":"Oncology meets immunology: The cancer-immunity cycle","volume":"39","author":"Chen","year":"2013","journal-title":"Immunity"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/nri3902","article-title":"Immunological hallmarks of stromal cells in the tumour microenvironment","volume":"15","author":"Turley","year":"2015","journal-title":"Nat. Rev. Immunol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"3121","DOI":"10.1002\/1521-4141(2001010)31:10<3121::AID-IMMU3121>3.0.CO;2-4","article-title":"CD56bright cells differ in their KIR repertoire and cytotoxic features from CD56dim NK cells","volume":"31","author":"Jacobs","year":"2001","journal-title":"Eur. J. Immunol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"e28977","DOI":"10.4161\/onci.28977","article-title":"Type II natural killer T cells foster the antitumor activity of CpG-oligodeoxynucleotides","volume":"3","author":"Zhao","year":"2014","journal-title":"Oncoimmunology"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s12016-019-08753-w","article-title":"Role of Mast Cells in Shaping the Tumor Microenvironment","volume":"58","author":"Komi","year":"2020","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s12307-013-0133-3","article-title":"Immunosuppressive mechanisms of regulatory dendritic cells in cancer","volume":"6","author":"Shurin","year":"2013","journal-title":"Cancer Microenviron."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Ghebremedhin, A., Athavale, D., Zhang, Y., Yao, X., Balch, C., and Song, S. (2024). Tumor-Associated Macrophages as Major Immunosuppressive Cells in the Tumor Microenvironment. Cancers, 16.","DOI":"10.3390\/cancers16193410"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1038\/s41423-023-00990-6","article-title":"Dendritic cell subsets in cancer immunity and tumor antigen sensing","volume":"20","author":"Salvi","year":"2023","journal-title":"Cell. Mol. Immunol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1084\/jem.188.12.2357","article-title":"The central role of CD4(+) T cells in the antitumor immune response","volume":"188","author":"Hung","year":"1998","journal-title":"J. Exp. Med."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1007\/s00262-019-02374-0","article-title":"CD4(+) T cells indirectly kill tumor cells via induction of cytotoxic macrophages in mouse models","volume":"68","author":"Bogen","year":"2019","journal-title":"Cancer Immunol. Immunother."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1186\/s12967-022-03807-8","article-title":"Pharmaceutical targeting Th2-mediated immunity enhances immunotherapy response in breast cancer","volume":"20","author":"Chen","year":"2022","journal-title":"J. Transl. Med."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Kravtsov, D.S., Erbe, A.K., Sondel, P.M., and Rakhmilevich, A.L. (2022). Roles of CD4+ T cells as mediators of antitumor immunity. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.972021"},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Andreu-Sanz, D., and Kobold, S. (2023). Role and Potential of Different T Helper Cell Subsets in Adoptive Cell Therapy. Cancers, 15.","DOI":"10.3390\/cancers15061650"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/s41416-022-02056-2","article-title":"Th2 cells inhibit growth of colon and pancreas cancers by promoting anti-tumorigenic responses from macrophages and eosinophils","volume":"128","author":"Jacenik","year":"2023","journal-title":"Br. J. Cancer"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/s41419-025-07385-7","article-title":"Overcoming immunotherapy resistance in gastric cancer: Insights into mechanisms and emerging strategies","volume":"16","author":"Luo","year":"2025","journal-title":"Cell Death Dis."},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Jin, X., Liu, Z., Yang, D., Yin, K., and Chang, X. (2022). Recent Progress and Future Perspectives of Immunotherapy in Advanced Gastric Cancer. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.948647"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"177","DOI":"10.5230\/jgc.2025.25.e4","article-title":"PD-L1 as a Biomarker in Gastric Cancer Immunotherapy","volume":"25","author":"Cho","year":"2025","journal-title":"J. Gastric Cancer"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1007\/s10120-024-01514-5","article-title":"Janus kinase inhibitor overcomes resistance to immune checkpoint inhibitor treatment in peritoneal dissemination of gastric cancer in C57BL\/6 J mice","volume":"27","author":"Du","year":"2024","journal-title":"Gastric Cancer"},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Peng, J., Zhu, Q., Peng, Z., Chen, Z., Liu, Y., and Liu, B. (2022). Patients with positive HER-2 amplification advanced gastroesophageal junction cancer achieved complete response with combined chemotherapy of AK104\/cadonilimab (PD-1\/CTLA-4 bispecific): A case report. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.1049518"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.21037\/jgo-24-757","article-title":"Challenges and prospects of LAG-3 inhibition in advanced gastric and gastroesophageal junction cancer: Insights from the RELATIVITY-060 trial","volume":"15","author":"Seghers","year":"2024","journal-title":"J. Gastrointest. Oncol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1038\/s41591-018-0136-1","article-title":"Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response","volume":"24","author":"Jiang","year":"2018","journal-title":"Nat. Med."},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Luo, X., Luo, B., Fei, L., Zhang, Q., Liang, X., Chen, Y., and Zhou, X. (2024). MS4A superfamily molecules in tumors, Alzheimer\u2019s and autoimmune diseases. Front. Immunol., 15.","DOI":"10.3389\/fimmu.2024.1481494"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"421","DOI":"10.4049\/jimmunol.2000498","article-title":"Dendritic Cells Require TMEM176A\/B Ion Channels for Optimal MHC Class II Antigen Presentation to Naive CD4(+) T Cells","volume":"207","author":"Lancien","year":"2021","journal-title":"J. Immunol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1189\/jlb.1109738","article-title":"Tmem176B and Tmem176A are associated with the immature state of dendritic cells","volume":"88","author":"Condamine","year":"2010","journal-title":"J. Leukoc. Biol."},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Drujont, L., Lemoine, A., Moreau, A., Bienvenu, G., Lancien, M., Cens, T., Guillot, F., B\u00e9riou, G., Bouchet-Delbos, L., and Fehling, H.J. (2016). ROR\u03b3t+ cells selectively express redundant cation channels linked to the Golgi apparatus. Sci. Rep., 6.","DOI":"10.1038\/srep23682"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"7763","DOI":"10.2147\/OTT.S179725","article-title":"Potential targets of TMEM176A in the growth of glioblastoma cells","volume":"11","author":"Liu","year":"2018","journal-title":"OncoTargets Ther."},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Guo, S., Liu, X., Zhang, J., Huang, Z., Ye, P., Shi, J., Stalin, A., Wu, C., Lu, S., and Zhang, F. (2023). Integrated analysis of single-cell RNA-seq and bulk RNA-seq unravels T cell-related prognostic risk model and tumor immune microenvironment modulation in triple-negative breast cancer. Comput. Biol. Med., 161.","DOI":"10.1016\/j.compbiomed.2023.107066"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1080\/15592294.2017.1341027","article-title":"Methylation of TMEM176A is an independent prognostic marker and is involved in human colorectal cancer development","volume":"12","author":"Gao","year":"2017","journal-title":"Epigenetics"},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Zhang, J., Chen, J., Shan, B., Lin, L., Dong, J., Sun, Q., Zhou, Q., and Han, X. (2021). Clinical Significance and Prognostic Value of Human Soluble Resistance-Related Calcium-Binding Protein: A Pan-Cancer Analysis. Front. Med., 8.","DOI":"10.3389\/fmed.2021.752619"},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Battista, T., Fiorillo, A., Chiarini, V., Genovese, I., Ilari, A., and Colotti, G. (2020). Roles of Sorcin in Drug Resistance in Cancer: One Protein, Many Mechanisms, for a Novel Potential Anticancer Drug Target. Cancers, 12.","DOI":"10.3390\/cancers12040887"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.drup.2017.10.003","article-title":"Not only P-glycoprotein: Amplification of the ABCB1-containing chromosome region 7q21 confers multidrug resistance upon cancer cells by coordinated overexpression of an assortment of resistance-related proteins","volume":"32","author":"Genovese","year":"2017","journal-title":"Drug Resist. Updates"},{"key":"ref_63","first-page":"237","article-title":"Overexpression of sorcin results in multidrug resistance in gastric cancer cells with up-regulation of P-gp","volume":"25","author":"He","year":"2011","journal-title":"Oncol. Rep."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.3892\/ol.2014.2543","article-title":"Overexpression of sorcin in multidrug-resistant human breast cancer","volume":"8","author":"Gong","year":"2014","journal-title":"Oncol. Lett."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s12013-014-0486-3","article-title":"Sorcin Enhances Metastasis and Promotes Epithelial-to-Mesenchymal Transition of Colorectal Cancer","volume":"72","author":"Tong","year":"2015","journal-title":"Cell Biochem. Biophys."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"4906","DOI":"10.1038\/s41388-021-01891-6","article-title":"A novel homeostatic loop of sorcin drives paclitaxel-resistance and malignant progression via Smad4\/ZEB1\/miR-142-5p in human ovarian cancer","volume":"40","author":"Zhang","year":"2021","journal-title":"Oncogene"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"104258","DOI":"10.18632\/oncotarget.22208","article-title":"Sorcin induces gastric cancer cell migration and invasion contributing to STAT3 activation","volume":"8","author":"Tuo","year":"2017","journal-title":"Oncotarget"}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/17\/21\/3483\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T05:42:01Z","timestamp":1761889321000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/17\/21\/3483"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,29]]},"references-count":67,"journal-issue":{"issue":"21","published-online":{"date-parts":[[2025,11]]}},"alternative-id":["cancers17213483"],"URL":"https:\/\/doi.org\/10.3390\/cancers17213483","relation":{},"ISSN":["2072-6694"],"issn-type":[{"type":"electronic","value":"2072-6694"}],"subject":[],"published":{"date-parts":[[2025,10,29]]}}}